Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NRC vs WORX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NRC Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 9–1 Matrix Metrics)

NRC Overall Winner 6-Pillar Tally: NRC 4 – 1 WORX (1 Tie) Matrix Metrics: NRC 9 – 1 WORX

As of Nov 16, 2026, National Research Corporation (NRC) is the stronger overall head-to-head candidate over SC WORX Corp (WORX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NRC carries a Unified Composite Score of 32.4/100 (SELL) at $26.33 (24.8x Forward P/E, 13.4% operating margin), whereas WORX carries 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin).

  • Composite vs. Pillar Nuance: While WORX currently prints a higher short-term Unified Composite Score (34.1/100 SELL vs. NRC 32.4/100 SELL), NRC captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (13.4% vs. -20.1% operating margin) and revenue trajectory (+11.0% vs. +3.4% YoY).
  • Defensive Composite Rating Caution: Although NRC compares more favorably head-to-head, both NRC (32.4/100 SELL) and WORX (34.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NRC vs WORX
NRC NASDAQ Head-to-Head Winner
National Research Corporation Common Stock (Delaware)
Services-Commercial Physical & Biological Research
$26.33
-0.87% 1D
Market Cap $563.6M
TTM Revenue $144M
Forward P/E 24.8x
Beta / 30D Vol 0.64β · 61% Vol
Unified Composite Score
32.4 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 64
RSI-14: 63.7 · SMA20: $24.29 · SMA50: $22.22
WORX NASDAQ
SC WORX Corp
Services-Computer Processing & Data Preparation
$1.15
-6.5% 1D
Market Cap $1.7M
TTM Revenue $2.9M
Forward P/E N/M
Beta / 30D Vol 23.01β · 208% Vol
Unified Composite Score
34.1 / 100 SELL
Tech 15.0 Fund 31.0 Flow 50.0 Mom 30.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 71
RSI-14: 71.4 · SMA20: $0.24 · SMA50: $0.24

6-Pillar Scorecard Institutional Category Breakdown (NRC 4 – 1 WORX)

Columns: Metric · NRC · WORX
1. Valuation Multiples NRC
Forward P/E 24.8x N/M
Trailing P/E 98.4x N/M
PEG Ratio 1.32x N/M
EV / Revenue 3.9x 0.6x
2. Growth & Scale NRC
Revenue Growth (YoY) +11.0% +3.4%
Earnings Growth (YoY) +16.7% +0.0%
TTM Revenue (USD) $144M $2.9M
Market Cap $563.6M $1.7M
3. Profitability & Quality NRC
Gross Margin 60.7% 44.7%
Operating Margin 13.4% -20.1%
Net Profit Margin 4.5% -80.5%
Return on Equity (ROE) 248.1% -38.1%
4. Balance Sheet & Cash Flow NRC
Cash Generation (TTM) $28M EBITDA -$914,262
Cash Flow Margin 19.3% EBITDA Mgn -31.2%
Net Cash / Leverage 248.1% ROE $77.66 Book/Sh · -38.1% ROE
Dividend Yield 2.40% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 98.1% (100th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat WORX
OpEx & R&D Intensity 47.3% of Rev ($68M) 64.8% of Rev ($1.9M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Health Information Services Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NRC (9) vs WORX (1)
Institutional Metric NRC WORX Criterion Row Edge
Market Capitalization
Scale
$563.6M $1.7M Larger Scale NRC
Trailing P/E Ratio
Valuation
98.4x N/M Lower Multiple NRC
Forward P/E Ratio
Valuation
24.8x N/M Lower Multiple NRC
Revenue Growth (YoY)
Growth
+11.0% +3.4% Higher Growth NRC
Operating Margin (TTM)
Profitability
13.4% -20.1% Higher Margin NRC
Net Profit Margin
Profitability
4.5% -80.5% Higher Margin NRC
Return on Equity (ROE)
Capital Efficiency
248.1% -38.1% Higher ROE NRC
52-Week Range Position
Momentum
92% ($12–$28) 17% ($0–$6) Stronger Trend NRC
Beta / 30D Volatility
Risk Regime
0.64β · 61% Vol 23.01β · 208% Vol Lower Realized Risk NRC
Unified Institutional Score
Composite Signal
32.4 / 100 (SELL) 34.1 / 100 (SELL) Higher Composite WORX
Trailing 12M Revenue (USD)
Operating Scale
$144M $2.9M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
60.7% 44.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.32x PEG · 3.9x EV/Rev N/M PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$28M EBITDA (248.1% ROE) -$914,262 ($77.66 Book/Sh · -38.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NRC +47.34 pp
NRC: +30.67% · WORX: -16.67%
3M Horizon WORX +117.74 pp
NRC: +110.64% · WORX: +228.38%
6M Horizon WORX +265.92 pp
NRC: +61.43% · WORX: +327.35%
1Y Horizon WORX +193.35 pp
NRC: +69.43% · WORX: +262.78%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NRC vs WORX. Trailing 12-month operating profitability (NRC 13.4% vs WORX -20.1%) and valuation multiples (NRC 24.8x vs WORX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

NRC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$144M
Gross Margin60.7%
Op. Margin13.4%
ROE / Fwd P/E248.1% · 24.8x
WORX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.9M
Gross Margin44.7%
Op. Margin-20.1%
ROE / Fwd P/E-38.1% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NRC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 98.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NRC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
WORX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WORX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NRC Moat Profile High-Margin Pricing Power Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $563.6M market capitalization and 13.4% operating margin.
OpEx & R&D Reinvestment 47.3% of Rev ($68M)
90D Engineering Disclosures 0 Published
WORX Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $1.7M market capitalization and -20.1% operating margin.
OpEx & R&D Reinvestment 64.8% of Rev ($1.9M)
90D Engineering Disclosures 0 Published

Investor FAQ NRC vs WORX Key Questions & Quantitative Answers

As of Nov 16, 2026, National Research Corporation (NRC) is the stronger overall head-to-head candidate over SC WORX Corp (WORX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NRC carries a Unified Composite Score of 32.4/100 (SELL) at $26.33 (24.8x Forward P/E, 13.4% operating margin), whereas WORX carries 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin). Composite vs. Pillar Nuance: While WORX currently prints a higher short-term Unified Composite Score (34.1/100 SELL vs. NRC 32.4/100 SELL), NRC captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (13.4% vs. -20.1% operating margin) and revenue trajectory (+11.0% vs. +3.4% YoY). Defensive Composite Rating Caution: Although NRC compares more favorably head-to-head, both NRC (32.4/100 SELL) and WORX (34.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

NRC leads the Growth & Scale pillar: NRC posts +11.0% YoY revenue growth and +16.7% YoY earnings growth on $144M TTM revenue (60.7% gross margin, 13.4% operating margin), compared with WORX at +3.4% YoY revenue growth and +0.0% YoY earnings growth on $2.9M TTM revenue (44.7% gross margin, -20.1% operating margin). On trailing 12-month operating scale, NRC generates $144M in USD-normalized revenue versus $2.9M for WORX. In operating R&D and SG&A reinvestment, NRC deploys 47.3% of Rev ($68M) (0 90-day corporate R&D disclosures) versus 64.8% of Rev ($1.9M) (0 disclosures) for WORX.

NRC screens cheaper on headline valuation multiples. NRC trades at 24.8x Forward P/E, 98.4x Trailing P/E, 1.32x PEG, and 3.9x EV/Revenue (19.3% EBITDA margin), whereas WORX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-31.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NRC (248.1% ROE) versus WORX (-38.1% ROE) capital efficiency.

In options market volatility and institutional positioning, NRC carries 98.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.64β · 61% Vol realized risk). By comparison, WORX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (23.01β · 208% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.